Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01496794 · ClinicalTrials.gov registry record
Endophthalmitis Cultures
A clinical trial, sponsored by Vanderbilt University.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01496794: Clinical Trial study, sponsored by Vanderbilt University.
NCT01496794 is a clinical trial that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01496794 was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The intent of this surveillance study will be to obtain written permission from patients with bacterial endophthalmitis in order to compare sterilization rates of their cultured bacterial isolates to standard therapy (vancomycin and ceftazidime) versus combination therapy with vancomycin, ceftazidime, and moxifloxacin. Research hypothesis: 1. Cultured bacterial isolates will demonstrate faster in vitro sterilization rates with combination treatment (vancomycin, ceftazidime, and moxifloxacin) compared to "standard therapy" with vancomycin and ceftazidime. 2. Longitudinal analysis of resistance patterns of cultured isolates will show increasing rates of multi-antibiotic resistance.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-04 |
Why NCT01496794 stopped before completion
NCT01496794 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01496794 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01496794 about?
NCT01496794 is a clinical study titled "Endophthalmitis Cultures". The intent of this surveillance study will be to obtain written permission from patients with bacterial endophthalmitis in order to compare sterilization rates of their cultured bacterial isolates to standard therapy (vancomycin and ceftazidime) versus combination therapy with vancomycin, ceftazidim...
What is the current status of trial NCT01496794?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2011-10. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01496794?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia